FoxA1 is a key mediator of hormonal response in breast and prostate cancer
about
Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico InvestigationAn Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate CancerTRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function.Identification of neuron selective androgen receptor inhibitors.Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.Molecular mechanisms regulating the hormone sensitivity of breast cancer.The changing role of ER in endocrine resistance.Androgen receptor-independent function of FoxA1 in prostate cancer metastasisStromal Androgen Receptor in Prostate Cancer Development and ProgressionAR function in promoting metastatic prostate cancerFOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer.Inducible super-enhancers are organized based on canonical signal-specific transcription factor binding elements.MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1.Androgen receptor profiling predicts prostate cancer outcome.The Emerging Roles of Forkhead Box (FOX) Proteins in Osteosarcoma.Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and PromisesForkhead box transcription factors in cancer initiation, progression and chemotherapeutic drug response.SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells.Clinical significance and prognostic value of Forkhead box A1 expression in human epithelial ovarian cancer.Acquisition of resistance to androgen deprivation therapy in salivary duct carcinoma: A case reportFOXA1 transcriptionally up-regulates cyclin B1 expression to enhance chondrosarcoma progression
P2860
Q26770051-D295367F-5F33-44BA-B556-400A89722376Q28550860-E3888550-55D0-4315-B279-8062E60BC762Q33557334-C8F714FB-3A26-4478-9705-C04C0DE0F58DQ33711488-02B8D1CA-93FA-47E1-913C-A2F189F5E398Q35677301-1AA0BEED-1651-4C14-A14F-115439E68F56Q35713360-9E3268DD-E4FC-497F-9B07-79D5BD517865Q36336601-B8E3D0E8-CA81-4114-9C64-61BFF59E9515Q36941029-F6EAB2F5-3B83-4460-95F2-494A9137E06BQ37629551-337ED8A8-7839-490C-8143-547724A451A1Q38178555-9EE45B3E-483E-444E-9882-1EFCE8F1170FQ38286227-0E75FB3C-724B-4188-B953-8D64A78E25EEQ38725396-EAA1A5B4-8E6B-4321-A1BD-F8587674514CQ39013543-4A7CDCE8-487D-4C1A-B114-BAE00C616EA1Q40493333-BDD62B6E-3CC2-47F1-BA01-E263DDC06BF2Q41180209-D48DFAAD-ABC0-474C-9FDF-8DC95A2FD69FQ41664067-F76736AC-34E9-4114-B880-CACB4D249E69Q42966267-F442CCB7-58F1-4D2D-9B74-B724EB8089FCQ47108793-C1B4D3FE-8915-43A4-B177-6E00A6DCD74AQ52655148-17FBBB53-3B79-4DEE-BF7B-05F3C77A3AF4Q58718493-605FA299-451D-4587-B468-D4D25A9FCCEEQ58790055-0CA6C4A8-CE7D-4BE4-ABCD-71231B79077A
P2860
FoxA1 is a key mediator of hormonal response in breast and prostate cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
FoxA1 is a key mediator of hormonal response in breast and prostate cancer
@en
FoxA1 is a key mediator of hormonal response in breast and prostate cancer
@nl
type
label
FoxA1 is a key mediator of hormonal response in breast and prostate cancer
@en
FoxA1 is a key mediator of hormonal response in breast and prostate cancer
@nl
prefLabel
FoxA1 is a key mediator of hormonal response in breast and prostate cancer
@en
FoxA1 is a key mediator of hormonal response in breast and prostate cancer
@nl
P2860
P356
P1476
FoxA1 is a key mediator of hormonal response in breast and prostate cancer
@en
P2093
Jason S Carroll
Jessica L L Robinson
P2860
P356
10.3389/FENDO.2012.00068
P577
2012-05-18T00:00:00Z